Baseline serum metabolomic profiles may help predict gout flare risk at ULT initiation and identify patients less likely to respond adequately to colchicine prophylaxis.
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results